TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
TNXP

Tonix Pharmaceuticals Holding Corp

Healthcare · Biotechnology

10.90$ -4.8% vs. previous close Closing price · As of: Sep 18, 2026

Investor relations

Report Dates

Investor relations overview for Tonix Pharmaceuticals Holding Corp (TNXP): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/09/2026.

Next report 11/09/2026
Last report 08/10/2026
Earnings surprise by quarter (%)
Q3 23 · -30.3 % 23 Q4 23 · 47.6 % 23 Q1 24 · 49.3 % 24 Q2 24 · 35.5 % 24 Q3 24 · 96.5 % 24 Q4 24 · -149.8 % 24 Q1 25 · 14.6 % 25 Q2 25 · -112.8 % 25 Q3 25 · -34.6 % 25 Q4 25 · -24.8 % 25 Q1 26 · -15.4 % 26 Q2 26 · 10.0 % 26

EPS estimate beaten

Full history 15 of 54 quarters (28%)
Last 16 quarters 9 of 16 quarters (56%)

Earnings Call Transcripts

Search all transcripts →

  • 08/10/2026 Earnings Call Q2 2026 Open →

News on This Stock

  • 09/08/2026 Tonix Pharmaceuticals Holding Corp. (TNXP): Other Events; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/18/2026 Tonix Pharmaceuticals Holding Corp. (TNXP): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Other Events · sec.gov Open ↗
  • 08/10/2026 Tonix Pharmaceuticals Holding Corp. (TNXP): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/03/2026 Tonix Pharmaceuticals Holding Corp. (TNXP): Regulation FD Disclosure; Other Events; Financial Statements and Exhibits · sec.gov Open ↗
  • 07/21/2026 Tonix Pharmaceuticals Holding Corp. (TNXP): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers · sec.gov Open ↗
  • 07/13/2026 Tonix Pharmaceuticals Holding Corp. (TNXP): Regulation FD Disclosure; Other Events; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?